References
Boyd et al (2009 Jul) Neurofibromatosis type 1. J Am Acad Dermatol 61(1):1–16
Johnson et al (1994) Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 14(1):641–645
Seminog et al (2013) Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer 108(1):193–198
Brunsvig et al (2011) Primary leptomeningeal melanocytosis in a 10-year-old girl: a challenging diagnosis with a poor prognosis. J Child Neurol 26(11):1444–1448
Stuckey et al (2007) Hyperintensity in the subarachnoid space on FLAIR MRI. Am J Roentgenol 189:913–921
Funding
No funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Author LH declares that he/she has no conflict of interest. Author MM declares that he/she has no conflict of interest. Author PC declares that he/she has no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Hauth, L., Montagna, M. & Cras, P. Stroke-like symptoms and leptomeningeal FLAIR hyperintensity in a neurofibromatosis type 1 patient with primary leptomeningeal melanoma. Acta Neurol Belg 118, 335–336 (2018). https://doi.org/10.1007/s13760-018-0931-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-018-0931-y